Citigroup have released a 44 page report on the uranium industry and uranium miners. It covers BHP, RIO, ERA and PDN. EXT gets a mention in the RIO section. It's a couple of paragraphs summarizing what we already know but this is good exposure as this gets it under the radar of institutional buyers. The report also says that RIO's stake gives it a "seat at the table".
So as not to breach hotcopper's posting rules, I'll just summarize some other interesting points.
- balanced uranium demand/supply until 2011, after that a supply deficit expected
- Supply from Kazakhstan and secondary uranium supply (uranium from decommissioned nukes, tailings reprocessing, inventory drawdowns) the big unknowns which could reduce the supply deficit
- Cigar Lake not expected until 2014 !
- Olympic Dam production increase not expected until 2016
- A number of reactors planned in the Western world likely to have significant delays. Expect more reactor build in China because of faster permitting processes, access to financing and cheaper/faster reactor build.
- China will likely eventually move to "cover uranium short". This means locking in supply. Acquisitions difficult in Aus & Canada due to political issues. Paladin possible target although Aussie assets make it tricky. I guess you can read into this that EXT is an easier target in political terms.
- recent acquisitions have been done at $US13-14 per pound for operating or close to production mines (Honeymoon, Karatau)
- Citi use a $US5 to $US10 price for undeveloped resources when calculating NPV
- Forums
- ASX - By Stock
- EXT
- citigroup report
EXT
excite technology services ltd
Add to My Watchlist
11.1%
!
1.0¢

citigroup report
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $20.72M |
Open | High | Low | Value | Volume |
0.9¢ | 1.0¢ | 0.8¢ | $31.15K | 3.390M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1600000 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 1109800 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1600000 | 0.009 |
6 | 1884688 | 0.008 |
7 | 5270700 | 0.007 |
4 | 2850000 | 0.006 |
2 | 1280000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 1109800 | 3 |
0.011 | 4227645 | 5 |
0.012 | 1982124 | 5 |
0.013 | 314500 | 2 |
0.014 | 1000000 | 1 |
Last trade - 15.23pm 27/06/2025 (20 minute delay) ? |
Featured News
EXT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online